NPC1L1 and cancer: [178] analyzed “The role of NPC1L1 in cancer” and concluded that NPC1L1 knockdown significantly reduces the levels of inflammatory markers such as pc‐Jun, p‐ERK, and caspase‐1 p20 in CRC.